Prognostic Implications and Efficacy of Catheter Ablation by Atrial Fibrillation Type.

atrial fibrillation catheter ablation health‐related quality of life paroxysmal atrial fibrillation persistent atrial fibrillation

Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
19 09 2023
Historique:
medline: 20 9 2023
pubmed: 8 9 2023
entrez: 8 9 2023
Statut: ppublish

Résumé

Background Catheter ablation (CA) for atrial fibrillation (AF) is preferred for paroxysmal AF (PAF) but selectively performed in patients with persistent AF (PersAF). This study aimed to investigate the prognostic differences and consequences of CA based on the AF type. Methods and Results Data from a multicenter AF cohort study were analyzed, categorizing patients as PAF or PersAF according to AF duration (≤7 or >7 days, respectively). A composite of all-cause death, heart failure hospitalization, stroke, and bleeding events during 2-year follow-up and changes in the Atrial Fibrillation Effect on Quality-of-life score were compared. Additionally, propensity score matching was performed to compare clinical outcomes of patients with and without CA in both AF types. Among 2788 patients, 51.6% and 48.4% had PAF and PersAF, respectively. Patients with PersAF had a higher incidence of the composite outcome (12.8% versus 7.2%;

Identifiants

pubmed: 37681532
doi: 10.1161/JAHA.122.029321
pmc: PMC10547271
doi:

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e029321

Références

J Am Coll Cardiol. 2016 Nov 15;68(20):2217-2228
pubmed: 27855811
N Engl J Med. 2020 Oct 1;383(14):1305-1316
pubmed: 32865375
Circulation. 2014 Dec 2;130(23):2071-104
pubmed: 24682348
Circulation. 2018 May 15;137(20):e623-e644
pubmed: 29661944
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Europace. 2010 Oct;12(10):1360-420
pubmed: 20876603
N Engl J Med. 2018 Feb 01;378(5):417-427
pubmed: 29385358
Circ Arrhythm Electrophysiol. 2014 Oct;7(5):841-52
pubmed: 25132078
Eur Heart J. 2013 Aug;34(31):2464-71
pubmed: 23594592
JACC Heart Fail. 2017 Jan;5(1):44-52
pubmed: 28034376
Stat Med. 2009 Nov 10;28(25):3083-107
pubmed: 19757444
N Engl J Med. 2021 Jan 28;384(4):316-324
pubmed: 33197158
JAMA. 2019 Apr 2;321(13):1275-1285
pubmed: 30874716
Heart Rhythm. 2022 Jul;19(7):1076-1083
pubmed: 35183738
Circ Cardiovasc Qual Outcomes. 2014 Nov;7(6):896-904
pubmed: 25387780
Eur Heart J. 2015 Feb 1;36(5):288-96
pubmed: 25209598
Heart Rhythm. 2010 Jun;7(6):835-46
pubmed: 20206320
Am Heart J. 2016 Dec;182:135-143
pubmed: 27914493
Circ Arrhythm Electrophysiol. 2011 Feb;4(1):15-25
pubmed: 21160035
J Am Coll Cardiol. 2003 May 21;41(10):1690-6
pubmed: 12767648
Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):393-402
pubmed: 26058720
N Engl J Med. 2008 Jun 19;358(25):2667-77
pubmed: 18565859
Eur Heart J. 2014 Jun 7;35(22):1448-56
pubmed: 24536084
J Am Coll Cardiol. 2022 May 17;79(19):1932-1948
pubmed: 35550691
Eur Heart J. 2016 May 21;37(20):1591-602
pubmed: 26888184
Circ Arrhythm Electrophysiol. 2017 Jan;10(1):
pubmed: 28077507
JAMA. 2001 Jun 13;285(22):2864-70
pubmed: 11401607
JAMA. 2003 Aug 27;290(8):1049-56
pubmed: 12941677
Am J Cardiol. 2022 Sep 01;178:43-51
pubmed: 35811145
JAMA Netw Open. 2019 Mar 1;2(3):e191145
pubmed: 30924896

Auteurs

Hiroshi Miyama (H)

Department of Cardiology Keio University School of Medicine Tokyo Japan.

Seiji Takatsuki (S)

Department of Cardiology Keio University School of Medicine Tokyo Japan.

Nobuhiro Ikemura (N)

Department of Cardiology Keio University School of Medicine Tokyo Japan.
Division of Molecular Epidemiology Jikei University School of Medicine Tokyo Japan.

Takehiro Kimura (T)

Department of Cardiology Keio University School of Medicine Tokyo Japan.

Yoshinori Katsumata (Y)

Department of Cardiology Keio University School of Medicine Tokyo Japan.

Shuhei Yamashita (S)

Department of Cardiology Keio University School of Medicine Tokyo Japan.

Koki Yamaoka (K)

Department of Cardiology Keio University School of Medicine Tokyo Japan.

Susumu Ibe (S)

Department of Cardiology Keio University School of Medicine Tokyo Japan.

Yuta Seki (Y)

Department of Cardiology Keio University School of Medicine Tokyo Japan.

Terumasa Yamashita (T)

Department of Cardiology Keio University School of Medicine Tokyo Japan.

Kenji Hashimoto (K)

Department of Cardiology Keio University School of Medicine Tokyo Japan.

Ikuko Ueda (I)

Department of Cardiology Keio University School of Medicine Tokyo Japan.

Koji Ueno (K)

Department of Cardiology Saiseikai Utsunomiya Hospital Tochigi Japan.

Takahiro Ohki (T)

Department of Cardiology Tokyo Dental College Ichikawa General Hospital Chiba Japan.

Keiichi Fukuda (K)

Department of Cardiology Keio University School of Medicine Tokyo Japan.

Shun Kohsaka (S)

Department of Cardiology Keio University School of Medicine Tokyo Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH